TipRanks
enGene Holdings (ENGN)
NASDAQ:ENGN
US Market
ENGN
enGene Holdings
RESEARCH TOOLSreports
Want to see ENGN full AI Analyst Report?

enGene Holdings (ENGN) Stock Forecast & Price Target

295 Followers
See the Price Targets and Ratings of:

ENGN Analyst Ratings

Hold
5Ratings
Hold
1 Buy
3 Hold
1 Sell
Based on 5 analysts giving stock ratings to
enGene
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ENGN Stock 12 Month Forecast

Average Price Target

$2.50
▲(28.21% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for enGene Holdings in the last 3 months. The average price target is $2.50 with a high forecast of $4.00 and a low forecast of $2.00. The average price target represents a 28.21% change from the last price of $1.95.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","11":"$11","2.75":"$2.75","5.5":"$5.5","8.25":"$8.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$4.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2.75,5.5,8.25,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.98,2.1353846153846154,2.290769230769231,2.4461538461538463,2.6015384615384614,2.7569230769230773,2.9123076923076923,3.0676923076923077,3.223076923076923,3.3784615384615386,3.533846153846154,3.689230769230769,3.844615384615385,{"y":4,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.98,2.02,2.06,2.1,2.14,2.18,2.2199999999999998,2.26,2.3,2.34,2.38,2.42,2.46,{"y":2.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.98,1.9815384615384615,1.983076923076923,1.9846153846153847,1.9861538461538462,1.9876923076923076,1.9892307692307691,1.9907692307692308,1.9923076923076923,1.9938461538461538,1.9953846153846153,1.996923076923077,1.9984615384615385,{"y":2,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.6,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.21,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.91,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.03,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.76,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.25,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.78,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.76,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.79,"date":1785542400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.855,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.98,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$4.00Average Price Target$2.50Lowest Price Target$2.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on ENGN
Yanan Zhu
Wells Fargo
Wells Fargo
$2
Hold
2.56%
Upside
Reiterated
10/02/26
enGene Holdings (ENGN) Receives a Hold from Wells Fargo
UBS Analyst forecast on ENGN
David Dai
UBS
UBS
$2
Hold
2.56%
Upside
Assigned
09/16/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Definium Therapeutics (NASDAQ: DFTX) and enGene Holdings (NASDAQ: ENGN)
H.C. Wainwright Analyst forecast on ENGN
Andres Y. Maldonado
H.C. Wainwright
H.C. Wainwright
$4
Buy
105.13%
Upside
Reiterated
09/09/26
Analysts Are Bullish on These Healthcare Stocks: enGene Holdings (ENGN), Structure Therapeutics, Inc. Sponsored ADR (GPCR)
Leerink Partners Analyst forecast on ENGN
Mani Foroohar
Leerink Partners
Leerink Partners
$2
Hold
2.56%
Upside
Reiterated
09/09/26
Analysts Conflicted on These Healthcare Names: enGene Holdings (NASDAQ: ENGN) and Waters (NYSE: WAT)
Morgan Stanley Analyst forecast on ENGN
Judah Frommer
Morgan Stanley
Morgan Stanley
―
Sell
―
Reiterated
08/12/26
Analysts Offer Insights on Healthcare Companies: Immix Biopharma (NASDAQ: IMMX), TScan Therapeutics (NASDAQ: TCRX) and enGene Holdings (NASDAQ: ENGN)
Guggenheim Analyst forecast on ENGN
Michael Schmidt
Guggenheim
Guggenheim
―
Hold
―
Reiterated
06/16/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: enGene Holdings (NASDAQ: ENGN), Medtronic (NYSE: MDT) and Roivant Sciences (NASDAQ: ROIV)
Piper Sandler Analyst forecast on ENGN
Allison Bratzel
Piper Sandler
Piper Sandler
$7→$4
Hold
105.13%
Upside
Downgraded
05/08/26
enGene downgraded to Neutral from Overweight at Piper SandlerenGene downgraded to Neutral from Overweight at Piper Sandler
Citizens JMP Analyst forecast on ENGN
Silvan Tuerkcan
Citizens JMP
Citizens JMP
―
Hold
―
Downgraded
05/08/26
enGene downgraded to Market Perform from Outperform at CitizensenGene downgraded to Market Perform from Outperform at Citizens
Raymond James Analyst forecast on ENGN
Sean McCutcheon
Raymond James
Raymond James
$27→$4
Buy
105.13%
Upside
Reiterated
05/08/26
enGene downgraded to Outperform from Strong Buy at Raymond JamesenGene downgraded to Outperform from Strong Buy at Raymond James
USmart Securities Analyst forecast on ENGN
Xin Yang NG‏
USmart Securities
Not Ranked
USmart Securities
$21.5
Buy
1002.56%
Upside
Initiated
04/13/26
WBB Securities Initiates a Buy Rating on enGene Holdings (ENGN)
Jefferies Analyst forecast on ENGN
Maury Raycroft
Jefferies
Jefferies
$28
Buy
1335.90%
Upside
Reiterated
02/25/26
Jefferies Reaffirms Their Buy Rating on enGene Holdings (ENGN)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on ENGN
Yanan Zhu
Wells Fargo
Wells Fargo
$2
Hold
2.56%
Upside
Reiterated
10/02/26
enGene Holdings (ENGN) Receives a Hold from Wells Fargo
UBS Analyst forecast on ENGN
David Dai
UBS
UBS
$2
Hold
2.56%
Upside
Assigned
09/16/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Definium Therapeutics (NASDAQ: DFTX) and enGene Holdings (NASDAQ: ENGN)
H.C. Wainwright Analyst forecast on ENGN
Andres Y. Maldonado
H.C. Wainwright
H.C. Wainwright
$4
Buy
105.13%
Upside
Reiterated
09/09/26
Analysts Are Bullish on These Healthcare Stocks: enGene Holdings (ENGN), Structure Therapeutics, Inc. Sponsored ADR (GPCR)
Leerink Partners Analyst forecast on ENGN
Mani Foroohar
Leerink Partners
Leerink Partners
$2
Hold
2.56%
Upside
Reiterated
09/09/26
Analysts Conflicted on These Healthcare Names: enGene Holdings (NASDAQ: ENGN) and Waters (NYSE: WAT)
Morgan Stanley Analyst forecast on ENGN
Judah Frommer
Morgan Stanley
Morgan Stanley
―
Sell
―
Reiterated
08/12/26
Analysts Offer Insights on Healthcare Companies: Immix Biopharma (NASDAQ: IMMX), TScan Therapeutics (NASDAQ: TCRX) and enGene Holdings (NASDAQ: ENGN)
Guggenheim Analyst forecast on ENGN
Michael Schmidt
Guggenheim
Guggenheim
―
Hold
―
Reiterated
06/16/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: enGene Holdings (NASDAQ: ENGN), Medtronic (NYSE: MDT) and Roivant Sciences (NASDAQ: ROIV)
Piper Sandler Analyst forecast on ENGN
Allison Bratzel
Piper Sandler
Piper Sandler
$7→$4
Hold
105.13%
Upside
Downgraded
05/08/26
enGene downgraded to Neutral from Overweight at Piper SandlerenGene downgraded to Neutral from Overweight at Piper Sandler
Citizens JMP Analyst forecast on ENGN
Silvan Tuerkcan
Citizens JMP
Citizens JMP
―
Hold
―
Downgraded
05/08/26
enGene downgraded to Market Perform from Outperform at CitizensenGene downgraded to Market Perform from Outperform at Citizens
Raymond James Analyst forecast on ENGN
Sean McCutcheon
Raymond James
Raymond James
$27→$4
Buy
105.13%
Upside
Reiterated
05/08/26
enGene downgraded to Outperform from Strong Buy at Raymond JamesenGene downgraded to Outperform from Strong Buy at Raymond James
USmart Securities Analyst forecast on ENGN
Xin Yang NG‏
USmart Securities
Not Ranked
USmart Securities
$21.5
Buy
1002.56%
Upside
Initiated
04/13/26
WBB Securities Initiates a Buy Rating on enGene Holdings (ENGN)
Jefferies Analyst forecast on ENGN
Maury Raycroft
Jefferies
Jefferies
$28
Buy
1335.90%
Upside
Reiterated
02/25/26
Jefferies Reaffirms Their Buy Rating on enGene Holdings (ENGN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
EHCEncompass Health
MDWDMediwound
OVIDOvid Therapeutics
ARDXArdelyx
STOKStoke Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering enGene Holdings

3 Months
Andres Y. MaldonadoH.C. Wainwright
Success Rate
7/12 ratings generated profit
58%
Average Return
-0.32%
Copying Andres Y. Maldonado's trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of -0.32% per trade.
1 Year
Andres Y. MaldonadoH.C. Wainwright
Success Rate
4/12 ratings generated profit
33%
Average Return
-26.92%
Copying Andres Y. Maldonado's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -26.92% per trade.
2 Years
Andres Y. MaldonadoH.C. Wainwright
Success Rate
2/12 ratings generated profit
17%
Average Return
-46.05%
Copying Andres Y. Maldonado's trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -46.05% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ENGN Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
7
4
2
2
2
Buy
0
0
0
0
0
Hold
11
11
4
3
4
Sell
1
1
2
1
1
Strong Sell
0
0
0
0
0
total
19
16
8
6
7
In the current month, ENGN has received 2 Buy Ratings, 4 Hold Ratings, and 1 Sell Ratings. ENGN average Analyst price target in the past 3 months is 2.50.
Each month's total comprises the sum of three months' worth of ratings.

ENGN Financial Forecast

ENGN Earnings Forecast

Next quarter’s earnings estimate for ENGN is -$0.46 with a range of -$0.55 to -$0.36. The previous quarter’s EPS was -$0.47. ENGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ENGN has Performed in-line its overall industry.
Next quarter’s earnings estimate for ENGN is -$0.46 with a range of -$0.55 to -$0.36. The previous quarter’s EPS was -$0.47. ENGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ENGN has Performed in-line its overall industry.
No data currently available

ENGN Sales Forecast

Next quarter’s sales forecast for ENGN is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ENGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ENGN has Performed in-line its overall industry.
Next quarter’s sales forecast for ENGN is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ENGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ENGN has Performed in-line its overall industry.

ENGN Stock Forecast FAQ

What is ENGN’s average 12-month price target, according to analysts?
Based on analyst ratings, enGene Holdings’s 12-month average price target is 2.50.
    What is ENGN’s upside potential, based on the analysts’ average price target?
    enGene Holdings has 28.21% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ENGN a Buy, Sell or Hold?
          enGene Holdings has a consensus rating of Hold which is based on 1 buy ratings, 3 hold ratings and 1 sell ratings.
            What is enGene Holdings’s price target?
            The average price target for enGene Holdings is 2.50. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $4.00 ,the lowest forecast is $2.00. The average price target represents 28.21% Increase from the current price of $1.95.
              What do analysts say about enGene Holdings?
              enGene Holdings’s analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of ENGN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.